Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma

被引：0
|
作者：
Patel, Krish [1 ]
Teschemaker, Anna [2 ]
Tian, Hongping [3 ]
Pyrih, Nick [3 ]
Kolvenbag, Geert [2 ]
Patel, Shweta [2 ]
Wahlstrom, Svea K. [4 ]
Cui, Lianzhou [3 ]
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] Cobbs Creek Hlth Care, Newtown Sq, PA USA
[4] AstraZeneca, Wilmington, DE USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-194523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7745 / 7745
页数：1
相关论文
共 50 条
  • [31] Treatment Outcomes of Elderly Patients with Mantle Cell Lymphoma: A Multi-center Real-World Data
    Gunes, Ebru Kilic
    Yavasoglu, Filiz
    Kucukyurt, Selin
    Aykas, Fatma
    Kaya, Sureyya Yigit
    Yilmaz, Munevver Irem Kok
    Yildirim, Murat
    Andic, Neslihan
    Gunes, Ahmet Kursad
    Karakus, Volkan
    Sevindik, Omur Gokmen
    Ozkurt, Zubeyde Nur
    Gunduz, Eren
    Ayli, Meltem
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025,
  • [32] Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients
    Saburi, Masuho
    Kodama, Yosuke
    Uraisami, Keiichi
    Takata, Hiroyuki
    Miyazaki, Yasuhiko
    Nishikawa, Takumi
    Sasaki, Hitohiro
    Abe, Miyuki
    Kohno, Kazuhiro
    Wada, Junpei
    Urabe, Shogo
    Kondo, Yoshiyuki
    Nakayama, Toshiyuki
    Ohtsuka, Eiichi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2023, 63 (03) : 205 - 208
  • [33] Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma
    Song, Yuqin
    Li, Jianyong
    Zhou, Keshu
    Ke, Xiaoyan
    Cai, Zhen
    Zhang, Huilai
    Yao, Tingting
    Xia, Zhen
    Wang, Yiqiu
    Lai, Peiqiong
    Liu, Xiaofeng
    Zhu, Jun
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 647 - 652
  • [34] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    BLOOD, 2018, 132
  • [35] Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan
    Goto, Hideki
    Kitawaki, Toshio
    Fujii, Nobuharu
    Kato, Koji
    Onishi, Yasushi
    Fukuhara, Noriko
    Yamauchi, Takuji
    Toratani, Kazunori
    Kobayashi, Hiroki
    Yoshida, Shota
    Shimo, Masatoshi
    Onodera, Koichi
    Senjo, Hajime
    Onozawa, Masahiro
    Hirata, Kenji
    Yokota, Isao
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (06) : 816 - 826
  • [36] Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan
    Hideki Goto
    Toshio Kitawaki
    Nobuharu Fujii
    Koji Kato
    Yasushi Onishi
    Noriko Fukuhara
    Takuji Yamauchi
    Kazunori Toratani
    Hiroki Kobayashi
    Shota Yoshida
    Masatoshi Shimo
    Koichi Onodera
    Hajime Senjo
    Masahiro Onozawa
    Kenji Hirata
    Isao Yokota
    Takanori Teshima
    International Journal of Clinical Oncology, 2023, 28 : 816 - 826
  • [37] Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trial
    Phillips, Tycel
    Wang, Michael
    Robak, Tadeusz
    Gallinson, David
    Stevens, Don
    Patel, Krish
    Ramadan, Safaa
    Wun, Chuan-Chuan
    Jurczak, Wojciech
    Smith, Stephen D.
    HAEMATOLOGICA, 2025, 110 (03) : 715 - 724
  • [38] Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
    Iacoboni, Gloria
    Iraola-Truchuelo, Josu
    Martinez-Cibrian, Nuria
    Bailen, Rebeca
    Corral, Lucia Lopez
    Sanchez, Jose M.
    Gonzalez, Ana Carolina Carolina Caballero
    Mussetti, Alberto
    Sancho, Juan-Manuel
    Hernani, Rafael
    Solano, Carlos
    Balari, Anna Sureda
    Briones, Javier
    Garcia-Sancho, Alejandro Martin
    Kwon, Mi
    Reguera, Juan Luis
    Barba, Pere
    BLOOD, 2020, 136
  • [39] Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
    Iacoboni, Gloria
    Villacampa, Guillermo
    Martinez-Cibrian, Nuria
    Bailen, Rebeca
    Lopez Corral, Lucia
    Sanchez, Jose M.
    Guerreiro, Manuel
    Carolina Caballero, Ana
    Mussetti, Alberto
    Sancho, Juan-Manuel
    Hernani, Rafael
    Abrisqueta, Pau
    Solano, Carlos
    Sureda, Anna
    Briones, Javier
    Martin Garcia-Sancho, Alejandro
    Kwon, Mi
    Luis Reguera-Ortega, Juan
    Barba, Pere
    CANCER MEDICINE, 2021, 10 (10): : 3214 - 3223
  • [40] Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study
    Epperla, Narendranath
    Hamadani, Mehdi
    Cashen, Amanda F.
    Ahn, Kwang W.
    Oak, Eunhye
    Kanate, Abraham S.
    Calzada, Oscar
    Cohen, Jonathon B.
    Farmer, Luke
    Ghosh, Nilanjan
    Tallarico, Michael
    Nabhan, Chadi
    Costa, Luciano J.
    Kenkre, Vaishalee P.
    Hari, Parameswaran N.
    Fenske, Timothy S.
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 528 - 535
12345